ZAI LAB LIMITED
Ownership & governance
Executives 5Directors 9Avg age 65Avg tenure 7y
YD
Ying Du
Chief Executive Officer
Age 61Since 2014-03-31Profile →
+13
Executives5
YD
Ying Du→
Chief Executive Officer
Age 61Since 2014-03-31
YC
Ya jing Chen
Director of Finance/CFO
Age 58Since 2023-07-06
RA
Rafael Amado
President
Age 62Since 2022-11-30
JS
Joshua Smiley
President
Age 56Since 2023-03-31
RB
Robert Brown
Chief Tech/Sci/R&D Officer
—Since 2023-08-31
Board of directors9
YD
Ying Du→
Chairman
Age 61Since 2014-03-31
JD
John Diekman→
Director/Board Member
Age 83Since 2016-12-31
PW
Peter Wirth→
Director/Board Member
Age 75Since 2016-12-31
WL
William David Lis→
Director/Board Member
Age 61Since 2018-09-30
LM
Lonnie Moulder→
Director/Board Member
Age 68Since 2018-12-31
SM
Scott Morrison→
Director/Board Member
Age 68Since 2021-10-12
RG
Richard Gaynor→
Director/Board Member
Age 76Since 2021-11-18
WL
Wing Yu Leung→
Director/Board Member
Age 55Since 2014-07-31
Shareholders5
| Name | Stake | Shares |
|---|---|---|
| RTW Investments LP | 5.797 % | 6,574,032 |
| TCG Crossover Management LLC | 5.214 % | 5,913,075 |
| RA Capital Management LP | 5.062 % | 5,740,762 |
| RA Capital Management LP | 5.032 % | 5,707,262 |
| Frazier Life Sciences Management LP | 1.677 % | 1,902,320 |
Catalog · 2026-07-09
Proxy officers23
| Name | Role | Since | Shares |
|---|---|---|---|
| Ying Du | Chairman | 2014-03-31 | - |
| John Diekman | Director or executive officer | 2017-01-01 | 99,769 |
| John Diekman | Director or executive officer | 2017-01-01 | 99,769 |
| John Diekman | Director/Board Member | 2016-12-31 | - |
| Lonnie Moulder | Director/Board Member | 2018-12-31 | - |
| Michel Vounatsos | Director/Board Member | 2023-01-06 | - |
| Michel Vounatsos | Director or executive officer | — | 50,416 |
| Michel Vounatsos | Director or executive officer | — | 50,416 |
Proxy · as of 2026-07-09
Institutional (13F)
Loading Form 13F holders…
Fund membership
Loading fund baskets…
Street consensus
Consensus noneMean target 33.14Range 24.25–50Analysts 12
24.25Mean 33.1450
- Strong buy 2
- Buy 9
- Hold 1
Broker actions40 of 53
| Firm | Action | To | Target | Date |
|---|---|---|---|---|
| Citigroup | Maintained | Buy | 45 | 2026-08-07 |
| Citigroup | Maintained | Buy | 44 | 2026-05-08 |
| JP Morgan | Maintained | Overweight | 32 | 2026-03-18 |
| Cantor Fitzgerald | Maintained | Overweight | 37 | 2026-02-27 |
| JP Morgan | Maintained | Overweight | 39 | 2026-02-05 |
| UBS | Initiated | Buy | 35 | 2026-01-07 |
| Citigroup | Maintained | Buy | 69 | 2025-08-11 |
| Leerink Partners | Maintained | Outperform | 75 | 2025-06-30 |
| Cantor Fitzgerald | Reiterated | Overweight | — | 2025-03-27 |
| JP Morgan | Maintained | Overweight | 51 | 2025-03-13 |
| Scotiabank | Initiated | Sector Outperform | 55 | 2025-03-07 |
| B of A Securities | Downgrade | Neutral | 36.1 | 2025-03-03 |
Firm rows and rating mix from Yahoo Finance; mean target is Yahoo’s aggregate until OpenFilings derives consensus from broker rows.